Skip to main content

Advertisement

Log in

Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast

  • Clinical trial
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Atypical vascular lesions (AVL) that occur in the field of prior radiation therapy for breast carcinoma are placed within the differential diagnosis with low grade angiosarcoma and other benign vascular lesions. Although considered a benign entity, the exact biological behavior of AVLs is not fully established because of the small number of cases reported in the literature. We aim to further characterize these lesions clinically and histopathologically, and to study their behavior. We report a series of 30 patients with AVL of the breast occurring after radiation exposure, diagnosed and treated at the European Institute of Oncology, Italy. Immunohistochemical study was performed in all cases, using CD31, D2-40, CD105, and Ki-67 antibodies. Twenty-seven patients were treated with standard doses of conventional adjuvant radiation therapy for the prior breast carcinoma. Three patients were treated with intraoperative radiotherapy with electrons. The post-radiation latency interval from breast carcinoma to AVL was 48.5 months (ranged from 1 to 146 months). Most of the lesions were classified as lymphatic type (78.6 %) based on D2-40 positivity. No extension into subcutaneous tissue or significant atypia was noted in all cases. Despite the fact that the AVL of our series have shown benign behavior in 93.3 %, one patient developed local recurrence of AVL, and two cases progressed to angiosarcoma at the previous AVL site. Further studies should be conducted to better understand the clinical behavior and to propose additional histopathologic diagnostic criteria to distinguish AVL from low grade angiosarcoma and those AVL with increased risk for malignant progression. Concerning current treatments of AVL, we recommend complete excision with free surgical margins and close follow up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Fraga-Guedes C, Gobbi H, Mastropasqua MG, Botteri E, Luini A, Viale G (2012) Primary and secondary angiosarcomas of the breast: a single institution experience. Breast Cancer Res Treat 132(3):1081–1088. doi:10.1007/s10549-011-1931-2

    Article  CAS  PubMed  Google Scholar 

  2. Gengler C, Coindre JM, Leroux A, Trassard M, Ranchere-Vince D, Valo I, Michels JJ, Guillou L (2007) Vascular proliferations of the skin after radiation therapy for breast cancer: clinicopathologic analysis of a series in favor of a benign process: a study from the French Sarcoma Group. Cancer 109(8):1584–1598. doi:10.1002/cncr.22586

    Article  PubMed  Google Scholar 

  3. Requena L, Kutzner H, Mentzel T, Duran R, Rodriguez-Peralto JL (2002) Benign vascular proliferations in irradiated skin. Am J Surg Pathol 26(3):328–337

    Article  PubMed  Google Scholar 

  4. Brenn T, Fletcher CD (2005) Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases. Am J Surg Pathol 29(8):983–996

    PubMed  Google Scholar 

  5. Mattoch IW, Robbins JB, Kempson RL, Kohler S (2007) Post-radiotherapy vascular proliferations in mammary skin: a clinicopathologic study of 11 cases. J Am Acad Dermatol 57(1):126–133. doi:10.1016/j.jaad.2006.10.025

    Article  PubMed  Google Scholar 

  6. Lucas DR (2009) Angiosarcoma, radiation-associated angiosarcoma, and atypical vascular lesion. Arch Pathol Lab Med 133(11):1804–1809. doi:10.1043/1543-2165-133.11.1804

    PubMed  Google Scholar 

  7. Sener SF, Milos S, Feldman JL, Martz CH, Winchester DJ, Dieterich M, Locker GY, Khandekar JD, Brockstein B, Haid M, Michel A (2001) The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer. J Am Coll Surg 193(1):22–28

    Article  CAS  PubMed  Google Scholar 

  8. Fineberg S, Rosen PP (1994) Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast carcinoma. Am J Clin Pathol 102(6):757–763

    CAS  PubMed  Google Scholar 

  9. Brodie C, Provenzano E (2008) Vascular proliferations of the breast. Histopathology 52(1):30–44. doi:10.1111/j.1365-2559.2007.02892.x

    Article  CAS  PubMed  Google Scholar 

  10. Brenn T, Fletcher CD (2006) Postradiation vascular proliferations: an increasing problem. Histopathology 48(1):106–114. doi:10.1111/j.1365-2559.2005.02293.x

    Article  CAS  PubMed  Google Scholar 

  11. Patton KT, Deyrup AT, Weiss SW (2008) Atypical vascular lesions after surgery and radiation of the breast: a clinicopathologic study of 32 cases analyzing histologic heterogeneity and association with angiosarcoma. Am J Surg Pathol 32(6):943–950

    Article  PubMed  Google Scholar 

  12. Di Tommaso L, Fabbri A (2003) Cutaneous angiosarcoma arising after radiotherapy treatment of a breast carcinoma. Description of a case and review of the literature. Pathologica 95(4):196–202

    PubMed  Google Scholar 

  13. Mandrell J, Mehta S, McClure S (2010) Atypical vascular lesion of the breast. J Am Acad Dermatol 63(2):337–340. doi:10.1016/j.jaad.2009.08.017

    Article  PubMed  Google Scholar 

  14. Diaz-Cascajo C, Borghi S, Weyers W, Retzlaff H, Requena L, Metze D (1999) Benign lymphangiomatous papules of the skin following radiotherapy: a report of five new cases and review of the literature. Histopathology 35(4):319–327

    Article  CAS  PubMed  Google Scholar 

  15. Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Yousef GM, Syro LV, Kovacs K, Lloyd RV (2011) Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res 31(6):2283–2290

    CAS  PubMed  Google Scholar 

  16. Hara H (2012) Endoglin (CD105) and claudin-5 expression in cutaneous angiosarcoma. Am J Dermatopathol 34(7):779–782. doi:10.1097/DAD.0b013e318252fc32

    Article  PubMed  Google Scholar 

  17. Shin SJ, Lesser M, Rosen PP (2007) Hemangiomas and angiosarcomas of the breast: diagnostic utility of cell cycle markers with emphasis on Ki-67. Arch Pathol Lab Med 131(4):538–544. doi:10.1043/1543-2165(2007)131[538:HAAOTB]2.0.CO;2

  18. Santi R, Cetica V, Franchi A, Pepi M, Cesinaro AM, Miracco C, Paglierani M, De Giorgi V, Delfino C, Difonzo EM, Pimpinelli N, Bianchi S, Sardi I, Santucci M, Massi D (2011) Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast skin following radiotherapy. Histopathology 58(3):455–466. doi:10.1111/j.1365-2559.2011.03770.x

    Article  PubMed  Google Scholar 

  19. Fernandez AP, Sun Y, Tubbs RR, Goldblum JR, Billings SD (2012) FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations. J Cutan Pathol 39(2):234–242. doi:10.1111/j.1600-0560.2011.01843.x

    Article  PubMed  Google Scholar 

  20. Mentzel T, Schildhaus HU, Palmedo G, Buttner R, Kutzner H (2012) Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases. Mod Pathol 25(1):75–85. doi:10.1038/modpathol.2011.134

    Article  CAS  PubMed  Google Scholar 

  21. Guo T, Zhang L, Chang NE, Singer S, Maki RG, Antonescu CR (2011) Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions. Genes Chromosomes Cancer 50(1):25–33. doi:10.1002/gcc.20827

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Jayalakshmy PS, Sivaram AP, Augustine J, Bindu P (2012) Postmastectomy-postirradiation atypical vascular lesion of the skin: report of 2 cases. Case Rep Pathol 2012:710318. doi:10.1155/2012/710318

    CAS  PubMed Central  PubMed  Google Scholar 

  23. Manner J, Radlwimmer B, Hohenberger P, Mossinger K, Kuffer S, Sauer C, Belharazem D, Zettl A, Coindre JM, Hallermann C, Hartmann JT, Katenkamp D, Katenkamp K, Schoffski P, Sciot R, Wozniak A, Lichter P, Marx A, Strobel P (2010) MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol 176(1):34–39. doi:10.2353/ajpath.2010.090637

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported partially by grants from Fundação de Amparo à Pesquisa de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), European Institute of Oncology, and Fundação de Amparo a Pesquisa de São Paulo (FAPESP).

Conflict of interest

The authors declare that they have no conflict of interest. This research complies with the Brazilian and Italian current laws. The authors declare that they do not have financial relationship with the organizations that sponsored this research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Gobbi.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fraga-Guedes, C., Gobbi, H., Mastropasqua, M.G. et al. Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast. Breast Cancer Res Treat 146, 347–354 (2014). https://doi.org/10.1007/s10549-014-3020-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-014-3020-9

Keywords

Navigation